Inventor · disambiguated record
Joseph M. Ahearn
Also filed as: AHEARN JOSEPH · AHEARN JOSEPH M · AHEARN JR JOSEPH M
14 granted patents·10 pending applications·188 citations·filing 1997–2022
92Inventor score
Files withUNIV PITTSBURGH7ALLEGHENY SINGER RES INSTITUTE5AHEARN JOSEPH M4ALLEGHENY SINGER RES INST2UNIV JOHNS HOPKINS MED2
Top patents by PatentIndex Score
24 records- 0189US7361517B2Real time method of detecting acute inflammatory conditionsUNIV PITTSBURGH·Filed 2005·Granted Apr 22, 2008·16 cites·12 claims
- 0289US6551595B1Smallpox inhibitor of complement enzymes (SPICE) protein and methods of inhibiting complement activationUNIV PENNSYLVANIA·Filed 2000·Granted Apr 22, 2003·28 cites·16 claims
- 0386US9495517B2Cell-bound complement activation products as diagnostic biomarkers for pre-lupusALLEGHENY-SINGER RES INST·Filed 2015·Granted Nov 15, 2016·4 cites·18 claims
- 0486US8126654B2Identification and monitoring of systemic lupus erythematosusAHEARN JOSEPH M·Filed 2009·Granted Feb 28, 2012·13 cites·13 claims
- 0583US7585640B2Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cellsUNIV PITTSBURGH·Filed 2005·Granted Sep 8, 2009·19 cites·16 claims
- 0683US6140472AUse of chimeric vaccinia virus complement control proteins to inhibit complementUNIV JOHNS HOPKINS MED·Filed 1998·Granted Oct 31, 2000·44 cites·2 claims
- 0782US7390631B2Diagnosis and monitoring of systemic lupus erythematosus and of sclerodermaUNIV PITTSBURGH·Filed 2002·Granted Jun 24, 2008·22 cites·21 claims
- 0876US7588905B2Identification and monitoring of systemic lupus erythematosusUNIV PITTSBURGH·Filed 2004·Granted Sep 15, 2009·13 cites·12 claims
- 0974US8080382B2Monitoring immunologic, hematologic and inflammatory diseasesAHEARN JOSEPH M·Filed 2004·Granted Dec 20, 2011·13 cites·16 claims
- 1072US9863946B2Cell-bound complement activation products as diagnostic biomarkers for pre-lupusALLEGHENY-SINGER RES INSTITUTE·Filed 2016·Granted Jan 9, 2018·1 cites·8 claims
- 1159US2023094382A1Methods and devices for determining a level of a complement activation productALLEGHENY SINGER RES INSTITUTE·Filed 2022·Application pending·0 cites
- 1258US2009298198A1Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cellsUNIV PITTSBURGH·Filed 2009·Application pending·0 cites
- 1357US5843778AUse of chimeric vaccinia virus complement control proteins to inhibit complementUNIV JOHNS HOPKINS MED·Filed 1997·Granted Dec 1, 1998·15 cites·7 claims
- 1456US2002023048A1Securities trading system with latency checkFiled 2001·Application pending·0 cites
- 1556US2002038276A1Securities trade state tracking method and apparatusFiled 2001·Application pending·0 cites
- 1653US2023375544A1Methods for Determining a Level of Cell-Bound Complement Activation ProductALLEGHENY SINGER RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1752US2010233752A1Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseasesCYPRESS BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 1851US2012122241A1Identification and monitoring of systemic lupus erythematosusAHEARN JOSEPH M·Filed 2012·Application pending·0 cites
- 1946US2008131914A1Assessing risk of cerebrovascular thrombosis by measuring c4dAHEARN JOSEPH M·Filed 2007·Application pending·0 cites
- 2045US2007202549A1Assessing risk of cerebrovascular thrombosis by measuring C4d on plateletsUNIV PITTSBURGH·Filed 2006·Application pending·0 cites
- 2142US12130288B2Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupusALLEGHENY SINGER RES INSTITUTE·Filed 2017·Granted Oct 29, 2024·0 cites·11 claims
- 2240US9709564B2Anti-lymphocyte autoantibodies as diagnostic biomarkersALLEGHENY-SINGER RES INST·Filed 2015·Granted Jul 18, 2017·0 cites·22 claims
- 2338US2011275060A1Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cellsUNIV PITTSBURGH·Filed 2011·Application pending·0 cites
- 2437US10067128B2Cell-bound complement activation product assays as companion diagnostics for antibody-based drugsALLEGHENY SINGER RES INSTITUTE·Filed 2016·Granted Sep 4, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Joseph M. Ahearn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →